Marsh & McLennan Chances for Deals Rise in Recession, CEO Says (Bloomberg)
Nov. 5 (Bloomberg) -- Marsh & McLennan Cos. , the second- biggest insurance broker, is capitalizing on the recession by buying companies that would have been out of reach in better times, Chief Executive Officer Brian Duperreault said.

Microsoft Reduces E-Mail Price to Keep Out Google (Update1) (Bloomberg)
Nov. 3 (Bloomberg) -- Microsoft Corp. is cutting its price for running customers’ e-mail systems as clients say the world’s largest software maker has been offering discounts to keep them from switching to Google Inc.

Marshall & Ilsley, Office Depot, Sprint: U.S. Equity Movers (Bloomberg)
Oct. 29 (Bloomberg) -- Shares of the following companies had unusual moves in U.S. trading . Stock symbols are in parentheses and prices are as of 4 p.m. in New York.

Elephant Insurance Hosts Grand Opening in Richmond, Virginia on October 21 (PR Newswire via Yahoo! Finance)
Elephant Insurance, a new Virginia car insurance provider, will host a Grand Opening Celebration and Open House on Wednesday, October 21, 2009 at its new 26,000 square foot facility located at 140 East Shore Drive in Glen Allen, Virginia.

Google Says Demand for Its Business Software Is Accelerating (Bloomberg)
Oct. 19 (Bloomberg) -- Google Inc. , fighting Microsoft Corp. for corporate customers, said demand for its business applications is accelerating and announced plans to start a global advertising campaign.

Sangretech Biomedical and Bostwick Laboratories Announce Amended License for Sangretech's Dendritic Cell Technology (Business Wire via Yahoo! Finance)
SEATTLE----Sangretech Biomedical LLC, a developer of dendritic cell therapies for cancer and infectious diseases, today announced it has executed an amended and restated license agreement with Bostwick Laboratories, Inc. providing Bostwick Scientific, the research division of Bostwick Laboratories, with exclusive rights to Sangretech’s dendritic cell technology in certain territories.